Charles Roncier, Vih.org The results of the DOXYPEP study confirm the benefit of taking doxycycline after sexual intercourse (PEP for post-exposure) in reducing the risk of bacterial sexually transmitted infections (STIs). Annie Luetkemeyer, from Zuckerberg San Francisco General Hospital, UCSF, presented these encouraging results at the 2022 Montreal International HIV/AIDS Conference. The DOXYPEP trial studied … Continuer la lecture de DOXYCYCLINE EFFECTIVE IN PREP